Health
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study – Times of India
India News: Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant…
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study
- News
- India News
- Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study
Continue Reading
-
Noosa News24 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business22 hours agoThese ASX 200 shares could rise 50% to 60%
-
General21 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General23 hours agoPort’s lease a ‘mistake’ as major parties flag takeover